Scientific Articles

Here are links to scientific magazines on-line with articles that directly relate to our work on a therapeutic vaccine for MG.
 
 
 
Possible Therapeutic Vaccines for Canine Myasthenia Gravis: Implication for the Human Disease and Associated Fatigue
Galin, F. Shawn , Cheryl L. Chrisman, James R. Cook Jr., Likang Xu, Patricia L. Jackson, Brett D. Noerager, Nathaniel M. Weathington and J. Edwin Blalock
Brain, Behavior, and Immunity, Volume 21, Issue 3, March 2007, Pages 323-331

 

 
Rational design of peptide vaccines for autoimmune disease: harnessing molecular recognition to fix a broken network
Weathington, Nathaniel M. and J. Edwin Blalock
Expert Review of Vaccines, Vol. 2, No. 1, Pages 61-73, 2003
 
 
The Role of Adjuvants in the Efficacy of a Peptide vaccine for Myasthenia Gravis
McAnally, James L. , Likang Xu, Matteo Villain and J.Edwin Blalock
Exp Biol Med Vo. 226(4): 307-311, 2001
 

Prevention and Reversal of Experimental Autoimmune Myasthenia Gravis by a Monoclonal Antibody against Acetylcholine Receptor-Specific T Cells. 
Xu, L., M. Villain, F.S. Galin, S. Araga, and J.E. Blalock.   
Cellular Immunology 208, 107-114  (2001)
 
 
A peptide vaccine that prevents experimental autoimmune myasthenia gravis by specifically blocking T cell help
Araga, Shigeru , Likang Xu, Kenji Nakashima, Matteo Villain and J. Edwin Blalock
FASEB J. 14: 185-196, 2000
 
 
Prevention of Experimental Autoimmune Myasthenia Gravis by a Monoclonal Antibody to a Complementary Peptide for the Main Immunogenic Region of the Acetylcholine Receptor. 
Araga, S., F.S. Galin, M. Kishimoto, A. Adachi, and J.E. Blalock.
The Journal of Immunology, 157: 386-392, 1996
 
 
Use of Complementary Peptides and Their Antibodies in B-Cell-Mediated Autoimmune Disease:  Prevention of Experimental Autoimmune Myasthenia Gravis with a Peptide Vaccine. 
Araga, S. and J.E. Blalock. 
IMMUNOMETHODS 5, 130-135, 1994
 
  
Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor.
S. Araga, R.D. LeBoeuf and J.E. Blalock.
Proc. Natl. Acad. Sci. USA Vol. 90 Immunology, 8747-8751, 1993
 
 
 
 
The article here under relates to research on the use of complementary peptide vaccine in MS
 
 
A complementary Peptite Vaccine That Induces T Cell Anergy and Prevents Experimental Allergic Neuritis in Lewis Rats
Araga, Shigeru, Masahiro Kishimoto, Sotoko Doi and Kenji Nakashima
Journal of Immunology, 163: 476-482, 1999